Nearly 70% of gynecological consultations for women in the perimenopausal or postmenopausal stage are driven by unexpected bleeding. This figure might surprise, given how often this symptom is downplayed as a temporary hormonal fluctuation or a whim of the body adjusting to a new phase of life. Yet, in gynecology clinics, that explanation never suffices. Bleeding after menopause, even if isolated or minimal, automatically triggers a sequence of precise checks. Why such vigilance for a symptom so common and, in most cases, not serious? It’s precisely because behind this seemingly ordinary symptom lies at times a warning signal that would be risky to ignore.
- Any postmenopausal bleeding should be reported to a doctor, even if light or isolated, as it constitutes the first symptom in 80 to 90% of endometrial cancers.
- Pelvic ultrasound is the initial examination: an endometrium thinner than 4–5 mm makes cancer very unlikely, while a thicker endometrium necessitates further tests such as biopsy or hysteroscopy.
- The majority of postmenopausal bleeds have benign causes (vaginal atrophy, polyps, fibroids), but factors like being overweight, diabetes, tamoxifen use, or Lynch syndrome increase the vigilance required.
- A postmenopausal bleed, never trivial: why you should never delay
- The pelvic ultrasound, the exam no one should skip
- Benign in the majority of cases, but an endometrial cancer not to be neglected
- Hormones, fibroids, cancer: what to remember when facing postmenopausal bleeding
A Postmenopausal Bleed, Never Trivial: Why You Should Never Delay
After menopause, periods disappear for months, or even years. So when a drop of blood reappears, even briefly, the reflex is often to think it’s just another hormonal spike, a small residual fluctuation without consequence. This interpretation, though understandable, carries no medical value until confirmed by a health professional. Postmenopausal bleeding represents roughly 5% of all gynecological investigations conducted in France, illustrating both its frequency and the need for a well-defined investigative framework.
The reason for this systematic vigilance rests on a number that speaks for itself: bleeding is the first symptom in about 80–90% of women with endometrial cancer. In other words, in the overwhelming majority of cases of this disease, it is this sign that alerted the patient and made it possible to initiate the necessary examinations. This statistical link explains why a gynecologist cannot settle for a hasty diagnosis based solely on a hormonal hypothesis. Waiting risks allowing a pathology to progress, even though, if detected early, it responds very well to treatment.
The Pelvic Ultrasound, the Exam Nobody Should Skip
Facing postmenopausal bleeding, the medical approach follows a well-established protocol. In France, the National Cancer Institute advises starting with an abdominal-pelvic and lymph node examination, before turning to a pelvic ultrasound performed both transabdominally and transvaginally. This painless, rapid test allows precise measurement of the thickness of the uterine lining, known as the endometrium.
For a postmenopausal woman not on hormone replacement therapy, this thickness should normally stay below 4 to 5 millimeters. This threshold is not arbitrary: when it is respected, the probability that cancer is driving the bleeding becomes very low, which immediately reassures many patients. Conversely, an endometrium thicker than the norm prompts further investigations. Some data show that ultrasound has a sensitivity close to 80% and a negative predictive value above 90%, making it a particularly reliable screening tool to exclude the most concerning cases. In more complex situations, hysteroscopy can supplement the assessment, an examination that provides direct visualization of the uterine cavity and is often even more precise than ultrasound alone.
Benign in the Majority of Cases, but Endometrial Cancer Not to Be Neglected
It would be exaggerated, and especially anxiety-provoking, to suggest that every postmenopausal bleed hides cancer. In reality, the vast majority of episodes have benign explanations: vaginal mucosal atrophy, polyps, fibroids, or effects of hormonal therapy. These causes, while sometimes uncomfortable, do not threaten patients’ health and are usually straightforward to treat.
Nevertheless, the risk of endometrial cancer does exist, and it must never be ruled out without examination. This risk increases with age, but also with well-identified factors such as overweight, diabetes, taking tamoxifen, or Lynch syndrome, a genetic predisposition to certain digestive and gynecological cancers. An organization dedicated to gynecologic cancers notes that more than 8 in 10 women diagnosed with uterine cancer had experienced postmenopausal bleeding beforehand. It is precisely this correlation that justifies the complete intolerance of gynecologists toward this symptom, even when it appears isolated, mild, or fleeting.
Hormones, Fibroids, Cancer: What to Remember When Facing Postmenopausal Bleeding
As autumn returns and medical consultations usually resume their routine after the summer holidays, this is also a reminder of a simple yet fundamental rule: postmenopausal bleeding is never a symptom to interpret yourself. Hormones, stress, or an improvised explanation cannot replace a reliable medical diagnosis. Only a consultation, supplemented if needed by a pelvic ultrasound, a biopsy, or a hysteroscopy, can determine with certainty the origin of the bleeding.
Here are the essential points to remember in this situation:
- All postmenopausal bleeding should be reported to a doctor, even if mild or single
- The pelvic ultrasound remains the first-line test to assess endometrial thickness
- An endometrium thinner than 4–5 millimeters makes cancer very unlikely
- Tissue biopsy helps confirm or definitively exclude a diagnosis
- Certain factors such as overweight, diabetes, or Lynch syndrome increase the necessary vigilance
This methodical approach, while rigorous, is far from alarmist: it aims primarily to reassure the concerned patients quickly, while promptly identifying the rarer cases that require specific management.
Ultimately, these medical recommendations reveal a truth often forgotten: the body keeps communicating well after menopause, and every signal deserves to be taken seriously. A bleed, no matter how subtle, should never be placed in the “hormonal inevitability” category without at least some verification. So the next time a doubt arises, there should be only one question on the mind: have I really taken the time to talk to my doctor?
